Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

EHA 2022: Ibrutinib combination with bendamustine-rituximab and rituximab maintenance as a first-line treatment for older patients with mantle cell lymphoma significantly improves PFS

EHA 2022: Ibrutinib combination with bendamustine-rituximab and rituximab maintenance as a first-line treatment...

EHA 2022: Decitabine shows similar survival and fewer adverse events compared to standard chemo in geriatric AML

EHA 2022: Decitabine shows similar survival and fewer adverse events compared to standard chemo in geriatric AML

EHA 2022: Quizartinib improves overall survival in adults with FLT3-ITD+ acute myeloid leukaemia

EHA 2022: Quizartinib improves overall survival in adults with FLT3-ITD+ acute myeloid leukaemia

$EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma$

EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory...

EHA 2022: Improved progression-free survival is achievable using targeted therapy combinations with venetoclax in fit patients with treatment-naïve chronic lymphocytic leukaemia

EHA 2022: Improved progression-free survival is achievable using targeted therapy combinations with venetoclax in...

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Drugs used to treat blood cancer could activate “sleeping” cancer-causing gene

Study reveals cause, potential precision therapies for aggressive type of lymphoma

Study reveals cause, potential precision therapies for aggressive type of lymphoma

Adolescent and young adult leukaemia survivors face higher mortality rates than the general population for decades after diagnosis

Adolescent and young adult leukaemia survivors face higher mortality rates than the general population for decades...

All cells are important: A roadmap to characterise lymphoma stroma

All cells are important: A roadmap to characterise lymphoma stroma

More from ecancer